Peter J. Mariani - Dec 13, 2024 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Signature
/s/ Peter J. Mariani
Stock symbol
CTSO
Transactions as of
Dec 13, 2024
Transactions value $
$19,294
Form type
4
Date filed
12/16/2024, 07:00 AM
Previous filing
Dec 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTSO Common Stock Purchase $19.3K +20K +5.24% $0.96 401K Dec 13, 2024 Direct F1, F2, F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects open market purchases made by the Reporting Person. The price reported in Column 4 is the weighted average price of purchases made in multiple transactions at prices ranging from $0.8902 to $1.09. The Reporting Person undertakes to provide full information regarding the number of shares purchased at each separate price within the range set forth herein upon request.
F2 Includes (a) 110,000 restricted stock units ("RSUs"), which will be settled into the Issuer's common stock, par value $0.001 per share (the "Common Stock"), upon vesting upon the earlier of (i) a "Change In Control" of the Issuer, as defined in the Reporting Person's employment agreement (the "Employment Agreement"), or (ii) the fourth anniversary from the date of grant, subject to the Reporting Person's continued service as of the applicable vesting date;
F3 (continued from footnote 2) (b) 65,000 RSUs, which shall vest as to one-half of the award on each of the first and second anniversaries of the date of grant, subject to the Reporting Person's continued service as of the applicable vesting date and will be settled into Common Stock upon vesting;
F4 (continued from footnote 3) (c) 175,000 RSUs, which will be settled into Common Stock upon a "Change In Control" of the Issuer, as defined in the Reporting Person's Employment Agreement, subject to the Reporting Person's continued service as of the applicable vesting date; and
F5 (continued from footnote 4) (d) 51,363 shares of Common Stock owned by the Reporting Person.